Moderna: ModernaTX, Inc: Moderna to Showcase Extensive Infectious Disease Research at ESCMID 2025
CAMBRIDGE, MA / ACCESS Newswire / April 7, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that the Company will present research across multiple infectious disease areas, including COVID-19, in...
Read full article »
Moderna is a Massachusetts-based biotechnology company that researches and develops mRNA therapeutics for the treatment of cardiovascular and autoimmune diseases.
Read more